Anfield Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2
| Closed | -$1.93K | – | 511 |
|
|
2024
Q1 | $1.93K | Buy |
+2
| New | +$1.93K | ﹤0.01% | 253 |
|
|
2023
Q1 | – | Sell |
-228
| Closed | -$165K | – | 89 |
|
|
2022
Q4 | $165K | Sell |
228
-229
| -50% | -$165K | 0.08% | 67 |
|
|
2022
Q3 | $315K | Buy |
457
+16
| +4% | +$11K | 0.15% | 64 |
|
|
2022
Q2 | $261K | Buy |
441
+64
| +17% | +$37.9K | 0.12% | 67 |
|
|
2022
Q1 | $263K | Buy |
377
+196
| +108% | +$137K | 0.1% | 70 |
|
|
2021
Q4 | $114K | Buy |
181
+165
| +1,031% | +$104K | 0.04% | 78 |
|
|
2021
Q3 | $10K | Sell |
16
-2
| -11% | -$1.25K | ﹤0.01% | 94 |
|
|
2021
Q2 | $10K | Buy |
+18
| New | +$10K | ﹤0.01% | 167 |
|